Lewis Waber

2.1k total citations · 1 hit paper
20 papers, 1.7k citations indexed

About

Lewis Waber is a scholar working on Clinical Biochemistry, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Lewis Waber has authored 20 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Clinical Biochemistry, 9 papers in Pediatrics, Perinatology and Child Health and 7 papers in Molecular Biology. Recurrent topics in Lewis Waber's work include Metabolism and Genetic Disorders (13 papers), Neonatal Health and Biochemistry (6 papers) and Mitochondrial Function and Pathology (4 papers). Lewis Waber is often cited by papers focused on Metabolism and Genetic Disorders (13 papers), Neonatal Health and Biochemistry (6 papers) and Mitochondrial Function and Pathology (4 papers). Lewis Waber collaborates with scholars based in United States, Australia and Austria. Lewis Waber's co-authors include Saul W. Brusilow, Mark L. Batshaw, Barbara K. Burton, David Valle, Catherine A. Neill, Austin L. Shug, Salvatore DiMauro, Emil Kakkis, Joseph Muenzer and Merry Passage and has published in prestigious journals such as New England Journal of Medicine, PEDIATRICS and The Journal of Urology.

In The Last Decade

Lewis Waber

20 papers receiving 1.6k citations

Hit Papers

Enzyme-Replacement Therapy in Mucopolysaccharidosis I 2001 2026 2009 2017 2001 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lewis Waber United States 14 898 649 552 377 286 20 1.7k
Julian Raiman Canada 24 738 0.8× 334 0.5× 559 1.0× 331 0.9× 439 1.5× 58 1.5k
Guillem Pintos‐Morell Spain 25 1.3k 1.5× 449 0.7× 490 0.9× 558 1.5× 526 1.8× 94 2.2k
C Borrone Italy 24 613 0.7× 197 0.3× 753 1.4× 165 0.4× 169 0.6× 86 1.7k
Anaïs Brassier France 19 714 0.8× 389 0.6× 608 1.1× 230 0.6× 168 0.6× 84 1.7k
Kimiyo Raymond United States 27 553 0.6× 675 1.0× 946 1.7× 168 0.4× 252 0.9× 71 1.9k
Rebecca S. Wappner United States 19 1.2k 1.4× 359 0.6× 897 1.6× 552 1.5× 175 0.6× 39 2.2k
B. William Uhlendorf United States 20 431 0.5× 650 1.0× 714 1.3× 95 0.3× 575 2.0× 26 1.6k
P Guibaud France 19 349 0.4× 290 0.4× 548 1.0× 122 0.3× 146 0.5× 60 1.1k
Wenjuan Qiu China 22 378 0.4× 606 0.9× 730 1.3× 142 0.4× 373 1.3× 146 1.5k
Anupam Chakrapani United Kingdom 19 466 0.5× 628 1.0× 546 1.0× 104 0.3× 175 0.6× 57 1.2k

Countries citing papers authored by Lewis Waber

Since Specialization
Citations

This map shows the geographic impact of Lewis Waber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lewis Waber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lewis Waber more than expected).

Fields of papers citing papers by Lewis Waber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lewis Waber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lewis Waber. The network helps show where Lewis Waber may publish in the future.

Co-authorship network of co-authors of Lewis Waber

This figure shows the co-authorship network connecting the top 25 collaborators of Lewis Waber. A scholar is included among the top collaborators of Lewis Waber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lewis Waber. Lewis Waber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Phillip, Eileen P. Treacy, Eric Crombez, et al.. (2008). Safety and efficacy of 22 weeks of treatment with sapropterin dihydrochloride in patients with phenylketonuria. American Journal of Medical Genetics Part A. 146A(22). 2851–2859. 79 indexed citations
2.
Harmatz, Paul, Chester B. Whitley, Lewis Waber, et al.. (2004). Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). The Journal of Pediatrics. 144(5). 574–580. 218 indexed citations
3.
Kakkis, Emil, Joseph Muenzer, George E. Tiller, et al.. (2001). Enzyme-Replacement Therapy in Mucopolysaccharidosis I. New England Journal of Medicine. 344(3). 182–188. 525 indexed citations breakdown →
4.
Boyadjiev, SA, et al.. (2000). Three cases of intravenous sodium benzoate and sodium phenylacetate toxicity occurring in the treatment of acute hyperammonaemia. Journal of Inherited Metabolic Disease. 23(2). 129–136. 44 indexed citations
5.
Gao, Jimin, Lewis Waber, Malcolm J. Bennett, K. Michael Gibson, & Jonathan C. Cohen. (1999). Cloning and mutational analysis of human malonyl-coenzyme A decarboxylase. Journal of Lipid Research. 40(1). 178–182. 48 indexed citations
6.
Mize, Charles E., Lewis Waber, Tim Anderson, & Michael J. Bennett. (1997). Hypoketonuric 3‐hydroxydicarboxylic aciduria in five patients with glycogen storage disease. Journal of Inherited Metabolic Disease. 20(3). 407–410. 3 indexed citations
7.
Dawson, D. Brian, Lewis Waber, Daniel E. Hale, & Michael J. Bennett. (1995). Transient organic aciduria and persistent lacticacidemia in a patient with short-chain acyl-coenzyme A dehydrogenase deficiency. The Journal of Pediatrics. 126(1). 69–71. 37 indexed citations
8.
Tomlinson, Gail E., et al.. (1994). Multiple coagulation defects and the Cohen syndrome. Clinical Genetics. 45(4). 212–216. 13 indexed citations
9.
Wilson, Golder N. & Lewis Waber. (1992). Joubert syndrome with facial dysmorphology. 6(3). 128–131. 2 indexed citations
10.
Waber, Lewis. (1990). Inborn Errors of Metabolism. Pediatric Annals. 19(2). 105–118. 16 indexed citations
11.
Stamberg, J., et al.. (1988). Duplication 17q mosaicism: an infant with features of Ellis-van Creveld syndrome.. Journal of Medical Genetics. 25(4). 258–260. 19 indexed citations
12.
Rich, Mark A., Audrey Heimler, Lewis Waber, & William A. Brock. (1987). Autosomal Dominant Transmission of Ureteral Triplication and Bilateral Amastia. The Journal of Urology. 137(1). 102–105. 14 indexed citations
13.
Nisen, Perry D., Judith Stamberg, Susana Velasco, et al.. (1986). The Molecular Basis of Severe Hemophilia B in a Girl. New England Journal of Medicine. 315(18). 1139–1142. 41 indexed citations
14.
Brusilow, Saul W., Mark M. Danney, Lewis Waber, et al.. (1984). Treatment of Episodic Hyperammonemia in Children with Inborn Errors of Urea Synthesis. New England Journal of Medicine. 310(25). 1630–1634. 181 indexed citations
15.
Waber, Lewis, Clair A. Francomano, Saul W. Brusilow, et al.. (1984). MEDIUM CHAIN ACYL-CoA DEHYDROGENASE (MCD) DEFICIENCY. Pediatric Research. 18. 302A–302A. 6 indexed citations
16.
Waber, Lewis, David Valle, Catherine A. Neill, Salvatore DiMauro, & Austin L. Shug. (1982). Carnitine deficiency presenting as familial cardiomyopathy: A treatable defect in carnitine transport. The Journal of Pediatrics. 101(5). 700–705. 191 indexed citations
17.
Brusilow, Saul W., David Valle, Mark L. Batshaw, & Lewis Waber. (1982). Screening for lethal genetic disease.. PubMed. 70(4). 647–8. 2 indexed citations
18.
Brusilow, Saul W., Mark L. Batshaw, & Lewis Waber. (1982). Neonatal Hyperammonemic Coma. Advances in Pediatrics. 29(1). 69–103. 33 indexed citations
19.
Brusilow, Saul W., David Valle, Mark L. Batshaw, & Lewis Waber. (1982). Screening for Lethal Genetic Disease. PEDIATRICS. 70(4). 647–648. 2 indexed citations
20.
Batshaw, Mark L., Saul W. Brusilow, Lewis Waber, et al.. (1982). Treatment of Inborn Errors of Urea Synthesis. New England Journal of Medicine. 306(23). 1387–1392. 205 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026